Hydrogen Sulfide

Hydrogen Sulfide

SCHEMBL5079696

S.c1ccc(C[N]Cc2ccccc2)cc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TRPA1 O75762 2/20 0.52
HPGD P15428 2/20 0.52
CYP3A4 P08684 1/20 0.52
MIF P14174 1/20 0.52
CALM1 P0DP23 1/20 0.50
GRIN1 Q05586 3/20 0.46
GRIN2B Q13224 3/20 0.46
NOS2 P35228 1/20 0.46
TSHR P16473 3/20 0.45
LOXL2 Q9Y4K0 2/20 0.45
IDO1 P14902 1/20 0.45
TP53 P04637 1/20 0.45
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAOB P27338 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
CASP1 P29466 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1653 0.97 ALDH1A1 (0.55) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL10325242 0.88 TRPA1 (0.48) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL2145 0.83 ALDH1A1 (0.50) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL2643014 0.81 MIF (0.50) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL17178869 0.80 ALDH1A1 (0.52) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL15506263 0.80 ALDH1A1 (0.52) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL19611522 0.80 ALDH1A1 (0.52) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL9120248 0.79 HTR2A (0.48) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL2098956 0.79 TDP1 (0.48) ALDH1A1TRPA1HPGDCYP3A4MIF
SCHEMBL3373294 0.79 TP53 (0.46) ALDH1A1TRPA1HPGDCYP3A4MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2790686-B1 TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM Zilentin AG (CH) 2021-03-10 EP claimed
EP-1951702-A2 DIURETIC-LIKE COMPOUND ANALOGS USEFUL FOR REGULATION OF CENTRAL NERVOUS SYSTEM DISORDERS NeuroTherapeutics Pharma, Inc. (US) 2008-08-06 EP claimed
WO-2007047447-A2 DIURETIC-LIKE COMPOUND ANALOGS USEFUL FOR REGULATION OF CENTRAL NERVOUS SYSTEM DISORDERS NEUROTHERAPEUTICS PHARMA, INC. (US) 2007-04-26 WO claimed